School of Medicine
Showing 1-50 of 84 Results
-
Alison Barrett
Postdoctoral Scholar, Immunity Transplant Infection
BioI'm an all-in-one biochemist, cell-culturist, and human-health enthusiast whose interests include therapeutics development, and tools for medical diagnostics.
I strive to maintain a healthy balance of breadth and depth in my areas of expertise, and have a strong affinity to interdisciplinary approaches. My background includes software development within the protein structure prediction module of the Rosetta software suite, design and initial development of cancer therapeutics, and basic research into understanding the mechanistic details of cell-cycle gene regulation.
My current research within the Tobias Lanz Lab aims to understand the role of certain targets of autoimmunity in Multiple Sclerosis and use this understanding to develop therapies and diagnostic aides. -
Cort Breuer
Ph.D. Student in Immunology, admitted Autumn 2022
BioCort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.
-
Caroline Duncombe
Postdoctoral Scholar, Immunity Transplant Infection
BioDr. Caroline Duncombe is a Postdoctoral Scholar in the Institute for Immunity, Transplantation, and Infection at Stanford University. Her research broadly explores how sex-based differences influence immune responses to infectious diseases. She applies systems-level approaches to investigate molecular and cellular mechanisms underlying immune variation, with the goal of informing more equitable and effective interventions.
Dr. Duncombe earned her PhD in Pathobiology from the University of Washington, where she pursued interdisciplinary research integrating systems biology, immunology, epidemiology, endocrinology, and parasitology. Her work has contributed to a deeper understanding of how sex and sex hormones shape host-pathogen interactions and vaccine responses.
In addition to her academic research, Dr. Duncombe is committed to science communication. She has produced science-focused comedy shows for over four years, using storytelling and humor to make complex scientific ideas more accessible.
Personal Website: carolinethescientist.com
LinkedIn Profile: linkedin.com/in/caroline-duncombe-phd-4ba11a124 -
David Furman
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
BioDavid Furman is the Director of the Stanford 1,000 Immunomes Project and the Buck Institute Artificial Intelligence Platform. Dr. Furman obtained his Doctoral degree in Biochemistry and Immunology (summa cum laude) from the School of Medicine, University of Buenos Aires, Argentina, for his work on cancer immune-surveillance. During his Postdoc at the laboratory of Professor Mark M Davis (Stanford), he conducted cutting-edge research in Data Science and Systems Immunology to answer scientific questions with strong potential for translational medicine, including the effect of aging, gender and common viral infections in immune system functioning. Dr. Furman’s work focuses in Data Science applied to inflammation and aging. Before joining as an Adjunct Investigator at the National Scientific and Research Council (CONICET), Buenos Aires, Argentina, Dr. Furman was Senior Scientist at the Institute for Immunity, Transplantation and Infection (ITI), Stanford, and his work involved the use of high-bandwidth/high-throughput technologies and Machine Learning tools to better define the health of the human immune system and its implications on age-related disease.
-
Anna Howley
Ph.D. Student in Immunology, admitted Autumn 2024
BioAnia Howley is an Immunology PhD student in the lab of Dr. Carolyn Bertozzi. She received her BS in Biology from College of the Holy Cross in 2022, where she investigated the function of APOBEC3G variants in the context of HIV infection. She subsequently joined Donald Ingber's lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Using an organ-on-chip model, she studied the effects of radiation-induced injury on human bone marrow and developed an in-vitro model of Shwachman Diamond Syndrome using shRNA-based knockdown in primary CD34+ progenitor cells.
Ania's broader research interests lie at the intersection of immunotherapy and mass spectrometry-based proteomics and glycoproteomics. -
Anandi Krishnan
Visiting Scholar, Institute for Immunity, Transplantation, and Infection Operations
BioDr. Krishnan is a translational scientist with experiences in engineering, biosciences, molecular genetics and hematology. Having recently completed her NIH clinical scientist career development award (NHGRI 1K08HG010061-01A1, 2018-24), and NIH-supported research re-entry (NCATS 3UL1TR001085-04S1, 2016-18), Anandi’s interests are in expanding our understanding of the multifaceted function of anucleate blood platelets and their parent megakaryocytes in human disease.
Her current work, applying platelet transcriptome profiling and machine learning principles, aims to nominate novel clinically relevant strategies for personalized cancer and antiplatelet/antithrombotic therapy. Continued development of this research is likely to identify key mechanistic variables in platelet- and megakaryocyte-specific response to health and disease.
Recent contributions in both computational and mechanistic components of platelet and blood research lay the groundwork for sustaining contributions to the field of hematology genomic medicine (e.g. Shen et al PMID 34755136, Seetharam et al PMID 36712071, Kelliher et al PMID 37961700, Thomas & Krishnan PMID 38175681, Abbonante et al PMID 38165147, Jutzi et al PMID 35763665, Campbell et al PMID 36194487). Anandi was also was one of the first non-MD PhD scientist to be awarded the NHGRI K08 Clinical Scientist Research Career Development Award, the HTRS Mid-Career Research Award, and the MPN Research Foundation Challenge Grant Award, reflecting her consistent efforts bridging basic and clinical disciplines.
Select other recognitions include:
Member, Editorial Board, Journal of Thrombosis and Haemostasis (2024-)
Ad hoc Reviewer, NIH CSR Cancer and Hematological Disorders Study Section (2023, 24)
Host Mentor, ISTH Training Fellowship, International Society for Thrombosis and Haemostasis (2023)
Member, Minority Recruitment Initiatives Subcommittee, American Society of Hematology (2022-26)
Team Science Leadership Program at Stanford Medicine (2022)
Peer Mentor, Pathology Stanford Network for Advancement and Promotion (2021)
Research Mentor, Meharry Medical College, Nashville, Meharry-Stanford initiative *mentee selected for oral presentation & won 2nd place at Meharry (2021)
Thrombosis & Hemostasis Societies of North America Young Investigator Award (2020)
Invited Member and Panelist, NSF RESET Conference (2020)
Invited Member/Panelist, iRelaunch Return to Work Conference, Stanford Alumni Association (2018)
Featured twice by NIH NCATS in the ‘Features & Briefs’ & ‘Diversity Awardee Profiles’ webpages (2017,18)
Complete list of publications: https://pubmed.ncbi.nlm.nih.gov/?term=anandi+krishnan&sort_order=asc
